Skip to content
aiqbench takeMachine Learning

aiqbench analysis

The paper addresses a practical gap in causal estimation: generic pretrained embeddings of rich post-treatment data (text, images, video) are not optimized for the nuisance tasks a semiparametric estimator needs. It proposes learning a shared adapter on top of frozen embeddings for outcome prediction, treatment propensity, and surrogate marginalization, then using cross-fitted orthogonal scores for inference. The A4 Alzheimer's trial validation is a useful real-world test, though readers should weigh the efficiency claims against the stated nuisance-rate conditions.
Source coveringarXiv
What this isA model's reading of the article and related coverage, written for aiqbench. Not the publisher's words.

SIRNET: Causal Adaptation of Pretrained Embeddings for Semiparametric Treatment-Effect Estimation Under Surrogacy

arXiv2 min read

arXiv:2610.14011v1 Announce Type: new Abstract: Modern experiments increasingly produce rich post-treatment objects---such as text, images, and video---that may provide early surrogate signals for outcomes that are delayed, expensive, or observed only for a subset of participants. A pretrained encoder can turn such an object into a strong generic embedding, but the embedding is not trained for the estimation tasks required by a causal estimator and may emphasize information irrelevant to the causal target. We propose SIRNET, a Surrogate-Informed Representation adaptation framework for neural-NETwork-based causal estimation in the presence of unstructured post-treatment surrogates. Starting from pretrained surrogate embeddings, SIRNET learns a shared adapter jointly for outcome prediction, treatment propensity, and arm-specific surrogate marginalization, beyond the generic pretraining objective. The resulting covariate and surrogate representations provide a common interface for these nuisance tasks. The final treatment-effect estimate and confidence interval are obtained from cross-fitted orthogonal scores that attain the semiparametric efficiency bound under the stated nuisance-rate conditions. We also validate SIRNET's performance in synthetic and semisynthetic experiments, as well as the Anti-Amyloid in Asymptomatic Alzheimer's Disease (A4) trial, using frozen pretrained brain-MRI embeddings as surrogates for a long-term outcome.

Abstract:Modern experiments increasingly produce rich post-treatment objects---such as text, images, and video---that may provide early surrogate signals for outcomes that are delayed, expensive, or observed only for a subset of participants. A pretrained encoder can turn such an object into a strong generic embedding, but the embedding is not trained for the estimation tasks required by a causal estimator and may emphasize information irrelevant to the causal target. We propose SIRNET, a Surrogate-Informed Representation adaptation framework for neural-NETwork-based causal estimation in the presence of unstructured post-treatment surrogates. Starting from pretrained surrogate embeddings, SIRNET learns a shared adapter jointly for outcome prediction, treatment propensity, and arm-specific surrogate marginalization, beyond the generic pretraining objective. The resulting covariate and surrogate representations provide a common interface for these nuisance tasks. The final treatment-effect estimate and confidence interval are obtained from cross-fitted orthogonal scores that attain the semiparametric efficiency bound under the stated nuisance-rate conditions. We also validate SIRNET's performance in synthetic and semisynthetic experiments, as well as the Anti-Amyloid in Asymptomatic Alzheimer's Disease (A4) trial, using frozen pretrained brain-MRI embeddings as surrogates for a long-term outcome.

Machine Learning (cs.LG); Methodology (stat.ME)

arXiv:2610.14011 [cs.LG]

(or arXiv:2610.14011v1 [cs.LG] for this version)

https://doi.org/10.48550/arXiv.2610.14011 Focus to learn more arXiv-issued DOI via DataCite (pending registration)

arXivLabs is a framework that allows collaborators to develop and share new arXiv features directly on our website.

Both individuals and organizations that work with arXivLabs have embraced and accepted our values of openness, community, excellence, and user data privacy. arXiv is committed to these values and only works with partners that adhere to them.

Have an idea for a project that will add value for arXiv's community? Learn more about arXivLabs.

Full text under the publisher's open licence · 278 words

Related coverage